Qube Research & Technologies Ltd - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,922,763
+49.4%
71,558
+98.2%
0.01%0.0%
Q2 2023$1,287,148
+4.2%
36,095
-25.8%
0.01%0.0%
Q1 2023$1,234,897
+133.0%
48,618
+321.8%
0.01%
+25.0%
Q1 2022$530,000
-72.8%
11,526
-51.0%
0.00%
-81.8%
Q2 2021$1,948,000
+472.9%
23,520
+339.1%
0.02%
+100.0%
Q4 2019$340,0005,3570.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,264$54,392,00033.22%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$216,228,00028.00%
L1 Capital Pty Ltd 296,024$19,629,0004.93%
Aquilo Capital Management, LLC 407,926$27,050,0004.89%
Evolutionary Tree Capital Management, LLC 72,948$4,837,0002.86%
ACUTA CAPITAL PARTNERS, LLC 108,000$7,161,0002.58%
First Light Asset Management, LLC 536,836$35,598,0002.36%
Parkman Healthcare Partners LLC 70,089$4,648,0001.08%
Hood River Capital Management LLC 357,082$23,678,0000.76%
Vanguard Capital Wealth Advisors 11,099$703,565,0000.60%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders